股本结构

单位:万股
公告日期 2025-11-12 2025-11-12 2025-08-13 2025-08-13 2025-06-16 2025-05-14
证券总股本 5934.73 5926.13 5923.55 5922.62 5746.40 4906.93
普通股本 5934.73 5926.13 5923.55 5922.62 5746.40 4906.93
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-10-31 2025-09-30 2025-07-31 2025-06-30 2025-06-16 2025-05-01
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-11-12 5934.73 未披露 定期报告 2025-10-31
2025-11-12 5926.13 未披露
更多>>
From June 30, 2025 to September 30, 2025 Exercise of common stock options Vesting of restricted stock units
2025-09-30
2025-08-13 5923.55 未披露 定期报告 2025-07-31
2025-08-13 5922.62 未披露
更多>>
From March 31, 2025 to June 30, 2025 Exercise of common stock options Vesting of restricted stock units Issuance of common stock under the ESPP Issuance of common stock and pre-funded warrants in the Public Offering, net of issuance costs of $13,875
2025-06-30
2025-06-16 5746.40 未披露
更多>>
Common stock offered 8,394,737 shares by the company
2025-06-16
2025-05-14 4906.93 未披露 定期报告 2025-05-01
2025-04-28 4906.60 未披露 定期报告 2025-04-25
2025-05-14 4903.87 未披露
更多>>
From January 1, 2025 to March 31, 2025 Exercise of common stock options Vesting of restricted stock units
2025-03-31
2025-03-13 4900.44 未披露 定期报告 2025-02-28
2025-03-13 4893.65 未披露
更多>>
From December 31, 2023 to December 31, 2024 Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs of $305 Exercise of common stock options Vesting of restricted stock units Issuance of common stock under the Sales Agreement, net of issuance costs of $1,373 Issuance of common stock under the Employee Stock Purchase Plan
2024-12-31
2024-11-13 4885.92 未披露 定期报告 2024-11-01
2024-11-13 4725.43 未披露
更多>>
From June 30, 2024 to September 30, 2024 Exercise of common stock options Vesting of restricted stock units
2024-09-30
2024-08-13 4723.72 未披露 定期报告 2024-08-01
2024-08-13 4717.35 未披露
更多>>
From March 31, 2024 to June 30, 2024 Vesting of restricted stock units Exercise of common stock options Issuance of common stock under the ESPP
2024-06-30
2024-05-14 4703.67 未披露 定期报告 2024-05-01
2024-04-26 4700.54 未披露 定期报告 2024-04-19
2024-04-18 4680.54 未披露 定期报告 2024-04-08
2024-05-14 4678.26 未披露
更多>>
From January 1, 2024 to March 31, 2024 Exercise of common stock options Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs of $170 Vesting of restricted stock units
2024-03-31
2024-03-14 4134.76 未披露 定期报告 2024-03-01
2024-03-14 4129.20 未披露
更多>>
From December 31, 2022 to December 31, 2023 Exercise of common stock options Vesting of restricted stock units Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger Issuance of common stock in the Financing Transaction, net of issuance costs of $4,955 Conversion of convertible preferred stock to common stock in connection with the Merger
2023-12-31
2023-11-09 4121.20 未披露 定期报告 2023-11-01
2023-11-09 4120.50 未披露
更多>>
From June 30, 2023 to September 30, 2023 Exercise of common stock options Vesting of restricted stock units
2023-09-30
2023-08-10 4115.11 未披露
更多>>
From March 31, 2023 to June 30, 2023 Exercise of common stock options
2023-06-30
2023-04-28 4111.48 未披露 定期报告 2023-04-25
2023-05-11 4110.63 未披露
更多>>
From January 1, 2023 to March 31, 2023 Conversion of convertible preferred stock to common stock in connection with the Merger Issuance of common stock in the Financing Transaction, net of issuance costs of $4,955 Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger Exercise of common stock options
2023-03-31
2023-02-22 4101.15 未披露
更多>>
Imara Inc. announced that it will effect a 1-for-4 reverse stock split of its common stock that will be effective on Thursday, February 23, 2023, prior to the closing of the Merger.
2023-02-24
2023-02-10 2623.39 未披露 定期报告 2023-02-06
2022-08-03 2628.73 未披露 定期报告 2022-06-30
2022-05-06 2627.57 未披露 定期报告 2022-04-30
2022-03-15 2628.73 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock under ATM and July 2021 offering, net of issuance costs of $579 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
2021-12-31
2021-11-09 2627.57 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock under ATM and July 2021 offering, net of issuance costs of $210 Exercise of stock options
2021-09-30
2021-08-06 2624.73 未披露 定期报告 2021-08-02
2021-07-16 2612.56 未披露
更多>>
1.Common stock offered 8333333 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 17,792,242 shares of common stock outstanding as of May 31, 2021.
2021-07-16
2021-08-06 1791.09 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock under ATM offering, net of issuance costs of $357 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
2021-06-30
2021-07-13 1779.22 未披露 定期报告 2021-05-31
2021-05-11 1764.05 未披露 定期报告 2021-05-06
2021-05-11 1761.65 未披露
更多>>
From December 31, 2020 to March 31, 2021 Exercise of stock options
2021-03-31
2021-03-05 1757.52 未披露 定期报告 2021-03-01
2021-03-05 1754.83 未披露
更多>>
From December 31, 2019 to December 31, 2020 Conversion of convertible preferred stock into common stock Issuance of Series B convertible preferred stock, net of issuance costs of $20 and beneficial conversion charge Accretion of Series B converted preferred stock Initial public offering,net of underwriting discounts, commissions and offering costs of $3,902 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
2020-12-31
2020-11-05 1740.74 未披露 定期报告 2020-10-30
2020-11-05 1737.71 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of stock options
2020-09-30
2020-08-14 1732.47 未披露
更多>>
from March 31, 2020 to June 30, 2020 Initial public offering, net of underwriting discounts,commissions and offering costs of $17 Exercise of stock options
2020-06-30
2020-05-07 1728.05 未披露 定期报告 2020-05-01
2020-05-07 1657.55 未披露 定期报告 2020-03-31
2020-03-12 1657.55 未披露
更多>>
1.Common stock offered by us 4,700,000 shares 2.The number of shares of our common stock to be outstanding after this offering is based on 11,875,465 shares of our common stock outstanding as of February 25, 2020, after giving effect to the conversion of 70,378,661 shares of our preferred stock into 11,172,955 shares of common stock upon the closing of this offering.
2020-03-12
From June 30, 2025 to September 30, 2025 Exercise of common stock options Vesting of restricted stock units
From March 31, 2025 to June 30, 2025 Exercise of common stock options Vesting of restricted stock units Issuance of common stock under the ESPP Issuance of common stock and pre-funded warrants in the Public Offering, net of issuance costs of $13,875
Common stock offered 8,394,737 shares by the company
From January 1, 2025 to March 31, 2025 Exercise of common stock options Vesting of restricted stock units
From December 31, 2023 to December 31, 2024 Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs of $305 Exercise of common stock options Vesting of restricted stock units Issuance of common stock under the Sales Agreement, net of issuance costs of $1,373 Issuance of common stock under the Employee Stock Purchase Plan
From June 30, 2024 to September 30, 2024 Exercise of common stock options Vesting of restricted stock units
From March 31, 2024 to June 30, 2024 Vesting of restricted stock units Exercise of common stock options Issuance of common stock under the ESPP
From January 1, 2024 to March 31, 2024 Exercise of common stock options Issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs of $170 Vesting of restricted stock units
From December 31, 2022 to December 31, 2023 Exercise of common stock options Vesting of restricted stock units Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger Issuance of common stock in the Financing Transaction, net of issuance costs of $4,955 Conversion of convertible preferred stock to common stock in connection with the Merger
From June 30, 2023 to September 30, 2023 Exercise of common stock options Vesting of restricted stock units
From March 31, 2023 to June 30, 2023 Exercise of common stock options
From January 1, 2023 to March 31, 2023 Conversion of convertible preferred stock to common stock in connection with the Merger Issuance of common stock in the Financing Transaction, net of issuance costs of $4,955 Issuance of common stock to former stockholders of Imara Inc. in connection with the Merger Exercise of common stock options
Imara Inc. announced that it will effect a 1-for-4 reverse stock split of its common stock that will be effective on Thursday, February 23, 2023, prior to the closing of the Merger.
From December 31, 2020 to December 31, 2021 Issuance of common stock under ATM and July 2021 offering, net of issuance costs of $579 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
From June 30, 2021 to September 30, 2021 Issuance of common stock under ATM and July 2021 offering, net of issuance costs of $210 Exercise of stock options
1.Common stock offered 8333333 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 17,792,242 shares of common stock outstanding as of May 31, 2021.
From March 31, 2021 to June 30, 2021 Issuance of common stock under ATM offering, net of issuance costs of $357 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
From December 31, 2020 to March 31, 2021 Exercise of stock options
From December 31, 2019 to December 31, 2020 Conversion of convertible preferred stock into common stock Issuance of Series B convertible preferred stock, net of issuance costs of $20 and beneficial conversion charge Accretion of Series B converted preferred stock Initial public offering,net of underwriting discounts, commissions and offering costs of $3,902 Exercise of stock options and issuance of stock under the Employee Stock Purchase Plan
From June 30, 2020 to September 30, 2020 Exercise of stock options
from March 31, 2020 to June 30, 2020 Initial public offering, net of underwriting discounts,commissions and offering costs of $17 Exercise of stock options
1.Common stock offered by us 4,700,000 shares 2.The number of shares of our common stock to be outstanding after this offering is based on 11,875,465 shares of our common stock outstanding as of February 25, 2020, after giving effect to the conversion of 70,378,661 shares of our preferred stock into 11,172,955 shares of common stock upon the closing of this offering.